“With the FDA approval of Zeposia, appropriate patients with relapsing forms of multiple sclerosis will have another oral treatment option with meaningful efficacy to help address the disease’s hallmark relapses and brain lesions,” said Samit Hirawat, MD, the company’s chief medical officer.
FDA Approves Zeposia (Ozanimod), Oral Th... - My MSAA Community
FDA Approves Zeposia (Ozanimod), Oral Therapy for All with Relapsing MS
Written by
bxrmom
To view profiles and participate in discussions please or .
3 Replies
•
Thanks for sharing this information!
Let’s hope it works well!
Not what you're looking for?
You may also like...
First Oral CGRP for Migraine – Ubrelvy – is Approved by FDA
I just received an alert about Ubrelvy getting approved for migraines. Looking forward to hearing...
Ocrevus: FDA Approves First Drug to Treat Two Forms of MS
Here is an excerpt from MSAA's article on the latest MS treatment news:
"On March 28, 2017, the...
Blood Test for MS Activity Gets FDA Breakthrough Designation
The US Food and Drug Administration (FDA) has granted breakthrough device designation to the...
MS Treatment
I have been on Tysabri and will be changing medication. My Dr suggested either Mavenclad or...
Pulse therapy for MS
My wife was diagnosed with MS in July this year. Following a 5-day corticosteroid pulse therapy...